共 13 条
[1]
DANHOF M, 1985, J PHARMACOL EXP THER, V232, P430
[2]
DINGEMANSE J, 1988, J PHARMACOL EXP THER, V246, P371
[3]
DINGEMANSE J, 1988, J PHARM PHARMACOL, V40, P522
[5]
GUDZINOWICZ BJ, 1977, ANAL DRUGS METABOLIT, V2, P1
[6]
DEVELOPMENT OF OPTIMIZATION STRATEGIES IN THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY
[J].
JOURNAL OF CHROMATOGRAPHY,
1989, 474 (01)
:149-162
[7]
OPTIMIZATION OF THERMOSPRAY CONDITIONS - EFFECT OF REPELLER POTENTIAL AND VAPORIZER TEMPERATURE
[J].
JOURNAL OF CHROMATOGRAPHY,
1987, 394 (01)
:117-122
[8]
PHARMACOKINETIC PHARMACODYNAMIC MODELING OF THE CENTRAL-NERVOUS-SYSTEM EFFECTS OF HEPTABARBITAL USING APERIODIC EEG ANALYSIS
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1990, 18 (05)
:459-481
[9]
TECHNIQUES FOR INCREASED USE OF THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY
[J].
JOURNAL OF CHROMATOGRAPHY,
1987, 385
:201-211
[10]
REPELLER EFFECTS IN DISCHARGE IONIZATION IN LIQUID AND SUPERCRITICAL-FLUID CHROMATOGRAPHY-MASS SPECTROMETRY USING A THERMOSPRAY INTERFACE .2. CHANGES IN SOME ANALYTE SPECTRA
[J].
JOURNAL OF CHROMATOGRAPHY,
1989, 478 (02)
:325-338